| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |